Cargando…

The suppressing effects of VEGF-mediated angiogenesis at different administration sequences of apatinib and transarterial embolization in vivo

BACKGROUND: To investigate the suppressing effects of vascular endothelial growth factor (VEGF)-mediated angiogenesis at different treatment schedules by applying apatinib combined with transarterial embolization (TAE). METHODS: Forty ideal liver cancer rat models were randomly divided into four gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Nan, Huang, Yong-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798221/ https://www.ncbi.nlm.nih.gov/pubmed/35117457 http://dx.doi.org/10.21037/tcr.2019.12.97

Ejemplares similares

Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways
por: Song, Jifu, et al.
Publicado: (2021)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
por: Zhang, Weihua, et al.
Publicado: (2021)

The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats
por: Li, Nan, et al.
Publicado: (2017)

Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma
por: Peng, Qiu-Xia, et al.
Publicado: (2017)

Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels
por: Schicho, Andreas, et al.
Publicado: (2016)

Transarterial Embolization for Shoulder Injury Related to Vaccine COVID-19 Administration
por: Fernández Martínez, Ana María, et al.
Publicado: (2022)

Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma
por: Gu, Huiying, et al.
Publicado: (2020)

The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Chen, Lei, et al.
Publicado: (2021)

A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo
por: Zhang, Yuan, et al.
Publicado: (2017)

Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib
por: Sun, Tao, et al.
Publicado: (2020)

Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma
por: Peng, Hong, et al.
Publicado: (2016)

Apatinib inhibits tumor growth and angiogenesis in PNET models
por: Wu, Shan, et al.
Publicado: (2018)

A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Sun, Tao, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kan, Xuefeng, et al.
Publicado: (2020)

Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
por: Pocha, Pauline Viviane, et al.
Publicado: (2021)

Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
por: Ju, Shuguang, et al.
Publicado: (2022)

Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization
por: Lee, Jung Eun, et al.
Publicado: (2017)

Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF
por: Tian, Bo, et al.
Publicado: (2020)

к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling
por: Yamamizu, Kohei, et al.
Publicado: (2013)

Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
por: Chen, Shiguang, et al.
Publicado: (2018)

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
por: Ouyang, Tao, et al.
Publicado: (2021)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
por: Jäger, Ronald, et al.
Publicado: (2011)

Transarterial embolization for management of severe postcoital bleeding
por: Eskandari, Armen, et al.
Publicado: (2016)

Transarterial Embolization of a Ruptured Renal Angiomyolipoma
por: Taki, Yasuhiro, et al.
Publicado: (2017)

Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma
por: Furumaya, Alicia, et al.
Publicado: (2019)

Safety and efficacy of transarterial embolization of hepatocellular adenomas
por: van Rosmalen, B. V., et al.
Publicado: (2019)

Transarterial Embolization in Neonatal Kasabach–Merritt Syndrome
por: Wang, Yinghao, et al.
Publicado: (2021)

Transarterial Embolization of a Parasellar Hypervascular Tumor
por: Kiyosue, Hiro, et al.
Publicado: (2020)

6-sialyllactose ameliorates dihydrotestosterone-induced benign prostatic hyperplasia through suppressing VEGF-mediated angiogenesis
por: Kim, Eun-Yeong, et al.
Publicado: (2019)

In vivo delivery of VEGF RNA and protein to increase osteogenesis and intraosseous angiogenesis
por: Rumney, Robin M. H., et al.
Publicado: (2019)

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study [Retraction]
Publicado: (2022)

Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization
por: Chu, Hai-Jui, et al.
Publicado: (2015)

Improving the results of transarterial embolization of type 2 endoleaks with the embolic polymer Onyx
por: Wojtaszek, Mikolaj, et al.
Publicado: (2016)

Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF
por: Cheng, Jiao, et al.
Publicado: (2019)

Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling
por: Cai, Xiaomin, et al.
Publicado: (2020)

Failed transarterial embolization of subserosal uterine arteriovenous malformation
por: Seo, Kyung Jin, et al.
Publicado: (2013)

Preventive transarterial embolization in upper nonvariceal gastrointestinal bleeding
por: Kaminskis, Aleksejs, et al.
Publicado: (2017)

Safety and efficacy of emergency transarterial embolization for mesenteric bleeding
por: Extrat, Chloé, et al.
Publicado: (2022)

Commentary: Transarterial Embolization in Neonatal Kasabach–Merritt Syndrome
por: Wang, Huaijie, et al.
Publicado: (2022)

Transarterial Embolization-Assisted Necrosis of a Facial Tumor
por: Dietz, Matthew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tu75h8ajpquokpl7k8mum228ld